Review Article
The Role of Bridging Therapy in Hepatocellular Carcinoma
Table 2
Comparison of patients, characteristics.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statistically significant (). Bridging therapy (BT); alpha-fetoprotein (AFP); hepatitis C cirrhosis (HCV). |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statistically significant (). Bridging therapy (BT); alpha-fetoprotein (AFP); hepatitis C cirrhosis (HCV). |